Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung...

Area of Science:

• Oncology
• Cancer Metabolism
• Biochemistry

Background:

• Polyamines are crucial for cell growth, and their metabolism is often altered in cancer.
• Targeting polyamine metabolism alone has shown limited success in cancer therapy.
• The mechanisms linking polyamine metabolism to cancer progression are not fully understood.

Purpose of the Study:

• To investigate the functional interconnection between polyamine catabolism and glutamine metabolism in lung cancer.
• To identify novel therapeutic strategies by targeting this metabolic crosstalk.

Main Methods:

• Genetic and pharmacological activation of spermidine/spermine N1-acetyltransferase 1 (SAT1).
• Assessing the impact of SAT1 activation on glutamine metabolism and oxidative stress.
• Evaluating the synergistic effects of combined therapeutic interventions in vitro and in vivo.

Main Results:

• Activation of SAT1 enhances glutamine conversion to glutamate and glutathione (GSH) synthesis.
• This metabolic shift supports lung cancer cell proliferation by reducing oxidative stress.
• Simultaneous glutamine limitation and SAT1 activation lead to reactive oxygen species (ROS) accumulation, growth inhibition, and cell death.
• Combined inhibition of glutamine transport, glutaminase, or GSH synthesis with SAT1 activation synergistically suppressed tumor growth.

Conclusions:

• Polyamine catabolism activation promotes glutamine metabolism, representing a targetable vulnerability in lung cancer.
• This study reveals a novel link between polyamine and glutamine metabolism.
• Cotargeting polyamine catabolism and glutamine metabolism pathways shows potential as a therapeutic strategy for lung cancer.